Has survival increased in cancer patients admitted to the ICU? Yes

Intensive Care Medicine

Volumn 40, Issue 10, 2014, Pages 1570-1572

  Mokart, Djamel ^a   Pastores, Stephen M ^b   Darmon, Michael ^c,d,e  

^a INSTITUT PAOLI CALMETTES   (France)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITÉ JEAN MONNET   (France)

^d University Jean Monnet of Saint Etienne EA3065   (France)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER SURVIVOR; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DYING; EDITORIAL; HEMATOLOGIC MALIGNANCY; HUMAN; INTENSIVE CARE; MOLECULARLY TARGETED THERAPY; MORTALITY; MULTICENTER STUDY (TOPIC); QUALITY OF LIFE; SEPSIS; SEPTIC SHOCK; CLASSIFICATION; HOSPITAL ADMISSION; INTENSIVE CARE UNIT; NEOPLASM; PROGNOSIS; STANDARDS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS;

HUMANS; INTENSIVE CARE UNITS; NEOPLASMS; PATIENT ADMISSION; PROGNOSIS; SURVIVAL RATE;

EID: 84918770292     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3433-2     Document Type: Editorial

References (16)

1. Tremblay LN, Hyland RH, Schouten BD, Hanly PJ (1995) Survival of acute myelogenous leukemia patients requiring intubation/ventilatory support. Clin Invest Med 18:19–24
2. Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ (1986) Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 12:317–324
3. Schapira DV, Studnicki J, Bradham DD et al (1993) Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 269:783–786
4. Schuster DP (1992) Everything that should be done–not everything that can be done. Am Rev Respir Dis 145:508–509
5. Azoulay E, Mokart D, Pène F et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium–a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 31:2810–2818
6. Zuber B, Tran T-C, Aegerter P et al (2012) Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 40:55–62
7. Legrand M, Max A, Peigne V et al (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40:43–49
8. Azoulay E, Lemiale V, Mokart D et al (2014) Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 40:1106–1114
9. Hill QA (2010) Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Rev 24:17–25
10. Peigne V, Rusinová K, Karlin L et al (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512–518
11. Khassawneh BY, White P, Anaissie EJ et al (2002) Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 121:185–188
12. Azoulay E, Alberti C, Bornstain C et al (2001) Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29:519–525
13. Gondos A, Bray F, Hakulinen T et al (2009) Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 20:564–573
14. Pulte D, Gondos A, Brenner H (2010) Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006-2010. Ann Oncol 21:335–341
15. Annane D, Aegerter P, Jars-Guincestre MC et al (2003) Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med 168:165–172
16. Oeyen SG, Benoit DD, Annemans L et al (2013) Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Med 39:889–898